Zocks Raises $45M to Expand Agentic AI for FAs
Zocks, an AI platform built for financial advisors, has raised $45 million in Series B funding in a round co-led by Lightspeed Venture Partners and QED Investors, with participation from Illuminate Financial and all existing investors, including Motive Partners, Expanse Venture Partners, Entrée Capital, and 14Peaks Capital. The raise brings the San Francisco–based company’s total funding to $65 million, following its $13.8 million Series A in March 2025.
With the new capital, Zocks plans to push beyond automating back-office tasks and further develop its agentic AI capabilities—technology designed to help advisors identify new planning opportunities across their entire book of business and act on them more quickly. The company is also investing in enterprise-grade integrations, security, and compliance to support larger advisory organizations.
“Clients want highly personalized service where advisors are anticipating their needs,” said Mark Gilbert, CEO and co-founder of Zocks. “We’re aggregating data and intelligence to identify revenue-producing activities, and to guide advisors to be more personalized and proactive across their entire book.”
Zocks says its platform saves advisors more than 10 hours per week by turning client conversations into structured, actionable data. Through two-way integrations with CRM systems, financial planning tools, tax software, and portfolio management platforms, Zocks automates workflows such as onboarding, account openings, meeting preparation and follow-ups, and document processing.
Advisors can query the platform to surface opportunities—such as identifying households without college savings plans, clients with legacy 401(k)s held outside management, or investors approaching required minimum distribution age.
More than 5,000 financial firms currently use Zocks, including enterprise clients such as Ameritas, Carson Group, Kestra Financial, and Osaic, as AI-driven personalization becomes a competitive imperative across wealth management.